Jiangsu Hansoh Pharmaceutical Group Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is VINORELBINE TARTRATE, USP, with a corresponding US DMF Number 31480.
Remarkably, this DMF maintains an Active status since its submission on April 13, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 10, 2017, and payment made on March 14, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II